Search
Medicus Pharma Ltd
MDCXAdd to Watchlist
0.164USD
-0.007-4.09%
Close 09-22 16:00（ET）
9.29MMarket Cap
LossP/E TTM
About Medicus Pharma Ltd Company
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. SkinJect Inc., a wholly owned subsidiary of the Company, is a development stage, life sciences company focused on commercializing novel, non-invasive treatment for basal cell skin cancer using a patented dissolvable microneedle patch to deliver a chemotherapeutic agent to eradicate tumors cells. It is conducting a randomized, controlled, double-blind, multicenter clinical study (SKNJCT-003) in the United States and Europe. It has also commenced a randomized, controlled, double-blind, multicenter clinical study (SKNJCT-004) in the UAE. Its subsidiary, Antev Limited, is a late clinical stage biotech company, developing Teverelix, a GnRH antagonist, as a first in market product for cardiovascular high-risk advanced prostate cancer patients and patients with first acute urinary retention relapse episodes due to enlarged prostate.
Medicus Pharma Ltd Profile
Ticker SymbolMDCX
Company nameMedicus Pharma Ltd
IPO dateOct 11, 2023
CEOBokhari (Raza)
Number of employees12
Security typeOrdinary Share
Fiscal year-endOct 11
Address300 Conshohocken State Rd.
CityCONSHOHOCKEN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code19428
Phone16105407515
Websitehttps://medicuspharma.com/
Ticker SymbolMDCX
IPO dateOct 11, 2023
CEOBokhari (Raza)
Company Executives of Medicus Pharma Ltd
Name
Name/Position
Position
Shareholding
Change
Dr. Raza Bokhari, M.D.
Dr. Raza Bokhari, M.D.
Executive Chairman, of the Board, Chief Executive Officer
Executive Chairman, of the Board, Chief Executive Officer
3.73M
+78.76%
Dr. Raza Bokhari, M.D.
Dr. Raza Bokhari, M.D.
Executive Chairman, of the Board, Chief Executive Officer
Executive Chairman, of the Board, Chief Executive Officer
3.73M
+78.76%
Ms. Carolyn F. Bonner
Ms. Carolyn F. Bonner
President, Chief Financial Officer
President, Chief Financial Officer
1.49M
+98.73%
Ms. Carolyn F. Bonner
Ms. Carolyn F. Bonner
President, Chief Financial Officer
President, Chief Financial Officer
1.49M
+98.73%
Mr. Patrick J. Mahaffy
Mr. Patrick J. Mahaffy
Independent Director
Independent Director
35.44K
--
Mr. Patrick J. Mahaffy
Mr. Patrick J. Mahaffy
Independent Director
Independent Director
35.44K
--
Mr. William L. (Bill) Ashton
Mr. William L. (Bill) Ashton
Independent Director
Independent Director
1.25K
--
Mr. William L. (Bill) Ashton
Mr. William L. (Bill) Ashton
Independent Director
Independent Director
1.25K
--
Dr. Faisal Mehmud, M.D.
Dr. Faisal Mehmud, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Edward J. Brennan, Jr., M.D.
Dr. Edward J. Brennan, Jr., M.D.
Chief Scientific Officer, Head - Research and Development Program
Chief Scientific Officer, Head - Research and Development Program
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Raza Bokhari, M.D.
Dr. Raza Bokhari, M.D.
Executive Chairman, of the Board, Chief Executive Officer
Executive Chairman, of the Board, Chief Executive Officer
3.73M
+78.76%
Dr. Raza Bokhari, M.D.
Dr. Raza Bokhari, M.D.
Executive Chairman, of the Board, Chief Executive Officer
Executive Chairman, of the Board, Chief Executive Officer
3.73M
+78.76%
Ms. Carolyn F. Bonner
Ms. Carolyn F. Bonner
President, Chief Financial Officer
President, Chief Financial Officer
1.49M
+98.73%
Ms. Carolyn F. Bonner
Ms. Carolyn F. Bonner
President, Chief Financial Officer
President, Chief Financial Officer
1.49M
+98.73%
Mr. Patrick J. Mahaffy
Mr. Patrick J. Mahaffy
Independent Director
Independent Director
35.44K
--
Mr. Patrick J. Mahaffy
Mr. Patrick J. Mahaffy
Independent Director
Independent Director
35.44K
--
FAQs
Who are the top five shareholders of Medicus Pharma Ltd?
The top five shareholders of Medicus Pharma Ltd are: Dr. Raza Bokhari, M.D.
How many institutions hold shares of Medicus Pharma Ltd (MDCX)?
As of 2026Q1, 38 institutions hold shares of Medicus Pharma Ltd, with a combined market value of approximately 4.15M, accounting for 7.52% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 1672664.00.